×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: TDP-43 RNA Granule Pathway
mechanism
1,601 words
KG: ent-prot-45e13b46
2026-03-29
kind:mechanism
section:mechanisms
state:published
evidence:strong
Contents
TDP-43 RNA Granule Pathway
⚙
Mechanism Info
Name
TDP-43 RNA Granule Pathway
Summary
Comprehensive mechanism page on TDP-43 nuclear-cytoplasmic shuttling, stress granule dynamics, and pathological aggregation cascade in ALS and FTD
Knowledge Graph
Related Hypotheses (27)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Phase-Separated Organelle Targeting
Score: 0.52
Stress Granule Phase Separation Modulators
Score: 0.49
Cryptic Exon Silencing Restoration
Score: 0.46
RNA Granule Nucleation Site Modulation
Score: 0.48
Cross-Seeding Prevention Strategy
Score: 0.45
Glycine-Rich Domain Competitive Inhibition
Score: 0.43
Transcriptional Autophagy-Lysosome Coupling
Score: 0.66
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A
Score: 0.51
Noradrenergic-Tau Propagation Blockade
Score: 0.51
Autophagosome Maturation Checkpoint Control
Score: 0.49
HSP90-Tau Disaggregation Complex Enhancement
Score: 0.44
Liquid-Liquid Phase Separation Modifier Therapy
Score: 0.42
VCP-Mediated Autophagy Enhancement
Score: 0.41
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41
Mitochondrial Calcium Buffering Enhancement via MCU Modulati
Score: 0.38
Synaptic Vesicle Tau Capture Inhibition
Score: 0.34
APOE-Dependent Autophagy Restoration
Score: 0.61
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53
Cell-Type Specific TFEB Modulation
Score: 0.48
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.45
Mitochondrial Transfer Pathway Enhancement
Score: 0.44
Mitochondrial RNA Granule Rescue Pathway
Score: 0.40
The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Score: 0.40
TFEB-PGC1α Mitochondrial-Lysosomal Decoupling
Score: 0.40
FOXO3-Longevity Pathway Epigenetic Reprogramming
Score: 0.39
RNA-Binding Competition Therapy for TDP-43 Cross-Seeding
Score: 0.37
Show 22 more
Related Analyses (30)
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
What determines the specificity of TDP-43-induced mitochondr
neurodegeneration · failed
How does chronic cGAS/STING activation downstream of TDP-43
neuroinflammation · failed
What mechanisms drive TDP-43 pathology specifically in Alzhe
neurodegeneration · failed
How does APOE4 mechanistically increase TDP-43 pathology fre
neurodegeneration · failed
What upstream mechanisms cause TDP-43 to trigger mPTP openin
neurodegeneration · failed
What mechanisms underlie TDP-43's contribution to cognitive
neurodegeneration · failed
What determines the selectivity and efficiency of intercellu
neurodegeneration · completed
What are the specific design principles for small molecules
medicinal chemistry · failed
Does DNAJB6 directly inhibit cross-seeding between tau, α-sy
neurodegeneration · failed
What is the therapeutic window between insufficient and toxi
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
What determines the specificity of RNA-protein interactions
neurodegeneration · failed
How do dilncRNAs specifically drive molecular crowding and p
neurodegeneration · completed
What determines the specificity of DDR protein recruitment t
neurodegeneration · completed
Do chronic stress granule inhibition strategies impair norma
neurodegeneration · failed
RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · failed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Show 25 more
Related Experiments (30)
cGAS/STING pathway activation by TDP-43-released mtDNA
exploratory · proposed · Score: 0.95
TDP-43 mutant mouse model cGAS/STING pathway analysis
validation · proposed · Score: 0.90
TDP-43 mitochondrial invasion and DNA release via mPTP
exploratory · proposed · Score: 0.90
TDP-43 mitochondrial invasion and mtDNA release in iPSC moto
exploratory · proposed · Score: 0.90
cGAS/STING pathway validation in TDP-43 mutant mice
validation · proposed · Score: 0.85
TDP-43 pathology prevalence and distribution in AD cases
exploratory · proposed · Score: 0.80
APOE4 association with TDP-43 pathology in AD
exploratory · proposed · Score: 0.75
Cognitive impact of TDP-43 pathology in AD patients
clinical · proposed · Score: 0.70
s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.40
Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40
Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40
C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study
clinical · proposed · Score: 0.40
Frontal and Temporal Lobe Selective Vulnerability in FTD — M
validation · proposed · Score: 0.40
FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.40
Multiscale Computational Modeling of Protein Aggregation Kin
validation · proposed · Score: 0.40
Presymptomatic GRN Carrier Intervention Timing — Biomarker-G
clinical · proposed · Score: 0.40
Prion Strain Diversity and Selective Vulnerability in CJD
clinical · proposed · Score: 0.40
Progranulin Replacement Therapy for FTD — Vector Development
clinical · proposed · Score: 0.40
Mechanism: Progranulin Loss and TDP-43 Pathology in FTD
validation · proposed · Score: 0.40
TDP-43 PET Ligand Development for FTD and ALS
clinical · proposed · Score: 0.40
Viral and Post-Infectious Mechanisms in ALS — Experiment Des
clinical · proposed · Score: 0.40
TRIM21-mediated K63-linked ubiquitination of G3BP1
exploratory · proposed · Score: 0.95
G3BP1-mediated stress granule assembly via liquid-liquid pha
exploratory · proposed · Score: 0.90
Endothelium-specific TBK1 knockdown in atherosclerosis model
validation · proposed · Score: 0.90
TBK1-PAK1IP1-PAK1 signaling pathway analysis
exploratory · proposed · Score: 0.90
LC-MS/Western blot analysis of TBK1 in atherosclerotic arter
exploratory · proposed · Score: 0.80
Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic
validation · proposed · Score: 0.40
Show 25 more